|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||28.85 - 30.20|
|52 Week Range||21.90 - 30.75|
|PE Ratio (TTM)||65.47|
|Earnings Date||Nov 14, 2017 - Nov 20, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||36.83|
Surmodics (SRDX) receives FDA's approval for PTA Balloon Catheter, which will boost its presence in the global peripheral artery disease market.
Q3 2017 Surmodics Inc Earnings Call
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced it has received U.S. Food and Drug Administration 510 and CE Mark clearance for its .014” low-profile percutaneous transluminal angioplasty balloon dilation catheter, designed for peripheral angioplasty procedures.